TSHR and Graves disease: The Graves’ disease (GD) specific autoantigen thyrotropin receptor (TSH-R) and the insulin-like growth factor 1 receptor (IGF-1R) are molecular targets on both thyrocytes and orbital fibroblasts (1, 2) playing pivotal roles in the pathogenesis of GD and thyroid eye disease (TED) (3, 4).